Ignite Creation Date:
2025-12-24 @ 9:22 PM
Ignite Modification Date:
2025-12-25 @ 7:08 PM
Study NCT ID:
NCT01236404
Status:
COMPLETED
Last Update Posted:
2013-05-21
First Post:
2010-11-05
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Phase 1/2a, Randomized, Double-Blind, Placebo-Controlled, Study to Assess Safety, Tolerability, PK and PD Response of PB1023 Injection Following Single and Multiple SQ Doses in Adults With Type 2 Diabetes Mellitus
Sponsor:
PhaseBio Pharmaceuticals Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-11
Start Date Type:
None
Primary Completion Date:
2011-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-11
Completion Date Type:
ACTUAL
First Submit Date:
2010-11-05
First Submit QC Date:
None
Study First Post Date:
2010-11-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2013-05-21
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2013-05-13
Last Update Post Date:
2013-05-21
Last Update Post Date Type:
ESTIMATED